GlassScriptPhysician profile
Wade Ritter
NPI 1962475665
$993.30
in general payments reported to CMS, 2019-2025
18 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.79 · 2020: $22.66 · 2021: $107 · 2022: $102 · 2023: $164 · 2024: $200 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $227.06 | 2022-2025 | Nuzyra |
| Abbott Laboratories | $148.91 | 2025 | Esprit |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $102.30 | 2021-2024 | Jublia |
| Horizon Therapeutics Plc | $89.41 | 2019-2023 | Krystexxa |
| Nevro Corp. | $53.42 | 2023-2024 | Senza |
| Abbvie INC. | $51.35 | 2023-2024 | Dalvance |
| Ibsa Pharma INC. | $42.09 | 2023-2024 | Tirosint, Licart, Tirosint |
| Sebela Pharmaceuticals INC. | $40.72 | 2020-2022 | |
| Amgen INC. | $39.70 | 2024-2025 | Krystexxa |
| Averitas Pharma INC. | $28.93 | 2023 | Qutenza |
| Zimmer Biomet Holdings, INC. | $26.96 | 2021 | |
| Grt US Holding, INC. | $26.43 | 2022 | |
| Bioventus LLC | $26.01 | 2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $22.10 | 2023 | Physio-Stim, Spinal-Stim |
| Melinta Therapeutics, LLC | $21.62 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $17.14 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Smith+Nephew, INC. | $14.87 | 2025 | Collagenase Santyl |
| Globus Medical, INC. | $14.28 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Ritter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.